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Combined small cell lung cancer is relatively rare. We report a case of combined small cell lung
carcinoma that was suspected to originate from a small pure ground-glass nodule; the tumor
was detected during a computed tomography (CT) health screening and observed periodically
over 4 years. Surgical resection was performed; histology showed features of both adenocarci-
noma and small cell carcinoma. The tumor histogenesis was interesting. Our result suggested
that if a solid component appeared as a pure ground-glass nodule, clinicians should pay
attention to both the CT -value and the doubling time. Not miss the timing of surgical resection
considering of possibility of combined small cell lung carcinoma.
& 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-
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Combined small cell lung cancer (CSCLC) is relatively rare
and occurs in approximately 2–14% of all cases of small cell
lung cancer (SCLC). [1,2]. The mechanism of CSCLC, which
is the simultaneous appearance of both SCLC and otheren access article under the CC BY-NC-ND license
K. Miura et al.18histological types, or the partial malignant transformation
from non-SCLC, is controversial [3,4]. We report a case of
CSCLC which was strongly suspected to originate from a
small pure ground-glass nodule (GGN) that had been
detected by during a computed tomography (CT) health
screening and observed periodically for 4 years.2. Case
A pure GGN on the left upper lobe was found in a 65-year-
old asymptomatic male smoker (80 pack years; high-risk
based on the Fleischner guidelines) by CT health screening
in June 2007. He came to our hospital in October 2007. His
physical examination and routine blood tests including
tumor markers such as CEA, SCC, CYFRA, and Pro-GRP were
unremarkable. High-resolution CT showed a pure GGN
located in the diffusely emphysematous lung parenchyma
at the left apex; it was 12 mm in size (Figure 1a). The
average CT value of GGN was 727 HU. We performed
periodic follow-up CT scans according to the guidelines of
the Japan Lung Cancer Society [5]. The CT image of GGN
showed little change from the initial one, including the size,
shape and average CT value of the nodule, until October
2008. In October 2009, GGN had enlarged slightly but its
density had not changed (709 HU). In January 2011, the
diameter of GGN increased to 14 mm. Moreover, a small
solid area (5 mm in diameter) was observed in GGN
(Figure 1b). The average CT value of GGN and the solid
component was 666 HU and +19 HU, respectively. Then, a
repeat CT was performed in June 2011. Both GGN and the
area of solid density area had increased in size, especially
the solid component, which was now +55 HU (Figure 1c). At
this point, we decided to perform surgical resection. First,
wedge resection was performed using video-assisted thoraco-
scopic surgery in July 2011. Because the lesion was diagnosed as
a large cell neuroendocrine carcinoma by the intraoperative
frozen specimen, we performed segmentectomy of left upper
division of the lung and hilar and mediastinum lymphadenect-
omy. The postoperative clinical course was unremarkable and
the patient was discharged from the hospital on the seventh
postoperative day. Histological ﬁndings of the specimen showedFigure 1 Computed tomography (CT) scan. (a) There was a small p
diameter of 12 mm and a CT value of 727 HU in June 2007. (b) A s
+19 HU in January 2011. (c) The solid density area had enlarged, afeatures of both adenocarcinoma and SCLC. The SCLC compo-
nent was 13 mm in diameter; the adenocarcinoma component
displayed minimally invasive adenocarcinoma. Immunohisto-
chemical testing was positive for Napsin A in the adenocarci-
noma component, and was positive for NCAM (CD56), CgA, and
SPN in the SCLC component (Figure 2). According to the 2004
WHO classiﬁcation [5], the lesion was diagnosed as CSCLC
(pT1aN0M0 Stage 1 A). No vessel or lymph invasion of the tumor
was detected (ly0, v0), and two courses of postoperative
adjuvant chemotherapy (carboplatin+CPT11) were completed.
However, brain metastasis was detected in April 2012, gamma
knife therapy was applied for the metastasis. Furthermore,
liver and bone metastases were found in June 2012. The patient
died in October 2012.3. Discussion
To our knowledge, this is the ﬁrst report of a case of CSCLC
that originated from a pure GGN in the lung. Small pure
GGNs of the lung, which have been detected by CT for
health screenings or for evaluating other diseases, are often
followed regularly for several years because they are
suspicious precancerous lesions (i.e., atypical adenomatous
hyperplasia) or adenocarcinoma in situ (AIS) [6], therefore
we did not resect this small nodule initially even though it
was 48 mm in size with risk as per the Fleischner guide-
lines. Several cases of pure GGNs have progressed to mixed
GGNs, which have been then diagnosed as minimally
invasive adenocarcinoma or invasive adenocarcinoma within
a few years. On the other hand, some cases of pure GGNs
have remained in the same form as the initial appearance
for several years [7]. In this case, GGN did not change
signiﬁcantly in size and the CT value for approximately
4 years; however a solid component appeared in GGN during
one CT examination. The solid part of GGN had quickly
grown in size; therefore, we decided upon surgical resection
at this point. We performed segmentectomy of left upper
lobe of the lung and lymphadenectomy because the tumor
lay in the apical portion of the lung and because we wished
to preserve his postoperative respiratory function. In spite
of a pathologically complete resection, the patient diedure ground-glass nodule (GGN) on the left upper lobe and with a
mall solid area (5 mm in diameter) appeared with a CT value of
nd its CT value was +55 HU.
Figure 2 Microscopic immuohistochemical ﬁndings of the tumor. The adenocarcinoma component contained minimal invasive
adenocarcinoma. The tumor was positive for Napsin A at adenocarcinoma component and positive for NCAM (CD56), CgA and SPN at
the small cell carcinoma of the lung component.
19Long-term observation after computed tomography screeningafter disease recurrence. Although biopsy of the metastases
had not been performed, we considered that these metas-
tases originated from the SCLC component because his Pro-
GRP levels elevated gradually after the metastasis was
detected.
It is difﬁcult to judge whether SCLC was caused contin-
gently at GGN or developed from adenocarcinoma after
further damage of the tumor suppressor genes. Some
adenocarcinomas develop into worse grade by acquiring
resistance to chemotherapy, such as epithelial mesenchymal
transition or SCLC-like change [8]. However, we did not give
the present patient chemotherapy or radiotherapy before
surgical resection. Because the frequency of SCLC combined
with adenocarcinoma, especially well-differentiated adeno-
carcinoma, is lower than that of pure SCLC; we suspect that
SCLC appeared contingently in this GGN. It is an interesting
point of tumor histogenesis.
We had to determine when we should have performed
surgical resection, because there had been no case report
similar as the present case to our knowledge. The CT value
and the tumor volume doubling time (TVDT) could help
answer this question. Sone [9,10] referred to the relativity
of the CT values and the aggressiveness of small peripheral
lung carcinoma and found that non-SCLC lesions of
4150 HU and 410 mm (or 4100 HU and 410 mm for
the solid portion of the tumor) were associated with an
unfavorable prognosis. Moreover, he denoted the CT values
and TVDT of each histological type: localized bronchioloal-
veolar carcinoma (i.e. AIS), invasive adenocarcinoma, and
SCLC. The mean CT values for AIS, invasive adenocarcinoma,
and SCLC were 537 HU, 186 HU and 14 HU, respectively.
The mean TVDT of AIS, invasive adenocarcinoma, and SCLCwere 536 days, 227 days, and 103 days, respectively. Wang
[11] et al. also reported that SCLC had the shortest doubling
time, which ranged from 54 to 132 days. In the present case,
at the point of appearance of solid lesion, January 2011, the
size of the nodule was 13 mm and the CT value of the solid
component was +19 HU. Using the rules from these reports,
these measurements suggested an unfavorable prognosis;
therefore we could have decided to perform the operation
at this time even if we were unable to predict the SCLC
component. In June 2011, the solid component had increased
to 10 mm in diameter and the CT value increased to +55 HU.
Furthermore, TVDTof the solid component was very short (69
days). These ﬁndings were strongly suggestive of a high-grade
malignancy including SCLC. Thus, if different parts of a tumor
nodule have different CT values and TVDT, we should
consider different histological subtypes during radiological
evaluation of the tumor.
In general, patients with CSCLC have a poor prognosis
similar to patients with SCLC [12]. CSCLC may often be
resistant to chemotherapy because of the non-small cell
carcinoma component [13]. On the other hand, Kondo et al.
reported that SCLC tumors that were over 10 mm in size had
poor prognosis compared with non-SCLC even if SCLC was only
stage IA [14]. Only early detection and early surgical resection
has the possibility of radical cure; therefore we should have
performed the operation when the solid lesion appeared.4. Conclusion
In summary, we have reported a case of CSCLC that
occurred in a small pure GGN after long-term follow-up.
K. Miura et al.20We believe that its pathophysiological mechanism was quite
interesting in terms of the embryology of SCLC. It is
important to pay attention to both the CT-value and
doubling time when a solid component appears in a pure
GGN, because the timing of surgical resection may be very
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